Piper Sandler on DexCom (DXCM): 'We Believe it is Time for Investors to Come Back to the Name'
Tweet Send to a Friend
Piper Sandler analyst Matt O\'Brien reiterated an Overweight rating and $90.00 price target on DexCom (NASDAQ: DXCM).The analyst commented: "Last ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
